Major Drugs - Coconut Creek, FL, US
Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.
Google translate widget
Nginx
Media Temple DNS
Google Font API
Mobile Friendly
Vimeo